E-LIB Suche - Ergebnisse für: Theuer, Amanda B.

1

Poster 146: ProKids ‐ Increasing Admissions to Acute Pediat..:

Conlee, Erin M. ; Theuer, Amanda B. ; Henning, Noelle B....
PM&R. 10 (2018) 9S1 - p. , 2018

2

The SoftHand Pro: Translation from Robotic Hand to Prosthet..:

Godfrey, Sasha B ; BIANCHI, MATTEO ; Zhao, Kristin...
info:eu-repo/semantics/altIdentifier/isbn/978-3-319-46668-2. , 2017

Link: http://hdl.handle.net/11..

3

The SoftHand Pro: Translation from Robotic Hand to Prosthet..:

Godfrey Sasha B ; Bianchi Matteo ; Zhao Kristin...
info:eu-repo/grantAgreement/EC/H2020/688857/. , 2016

Link: https://zenodo.org/recor..

4

Inhibition of multiple vascular endothelial growth factor r..:

Sini, P. (Patrizia) ; Samarzija, I. (Ivana) ; Baffert, F. (Fabienne)...
http://repub.eur.nl/pub/29203. , 2008

Link: http://repub.eur.nl/pub/..

5

The SoftHand Pro: Functional evaluation of a novel, flexibl..:

Godfrey, Sasha Blue ; Zhao, Kristin D. ; Theuer, Amanda...
PLOS ONE. 13 (2018) 10 - p. e0205653 , 2018

Link: https://doi.org/10.1371/..

6

Endoglin inhibitor TRC105 with or without bevacizumab for b..:

Ahluwalia, Manmeet S. ; Rogers, Lisa R. ; Chaudhary, Rekha...
Communications Medicine. 3 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

86/90Y-Based Theranostics Targeting Angiogenesis in a Murin..:

Ehlerding, Emily B. ; Ferreira, Carolina A. ; Aluicio-Sarduy, Eduardo...
Molecular Pharmaceutics. 15 (2018) 7 - p. 2606-2613 , 2018

Link: https://doi.org/10.1021/..

8

An Open Label Phase Ib Dose Escalation Study of TRC105 (Ant..:

Choueiri, Toni K. ; Michaelson, M. Dror ; Posadas, Edwin M....
The Oncologist. 24 (2018) 2 - p. 202-210 , 2018

Link: https://doi.org/10.1634/..

9

Targeting angiogenesis for radioimmunotherapy with a 177Lu-..:

Ehlerding, Emily B. ; Lacognata, Saige ; Jiang, Dawei...
European Journal of Nuclear Medicine and Molecular Imaging. 45 (2017) 1 - p. 123-131 , 2017

Link: https://doi.org/10.1007/..

10

In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theran..:

Chen, Feng ; Hong, Hao ; Goel, Shreya...
ACS Nano. 9 (2015) 4 - p. 3926-3934 , 2015

Link: https://doi.org/10.1021/..

11

Modulation of circulating protein biomarkers following TRC1..:

Liu, Yingmiao ; Starr, Mark D. ; Brady, John C....
Cancer Medicine. 3 (2014) 3 - p. 580-591 , 2014

Link: https://doi.org/10.1002/..

12

Effects of the combination of TRC105 and bevacizumab on end..:

Liu, Yingmiao ; Tian, Hongyu ; Blobe, Gerard C....
Investigational New Drugs. 32 (2014) 5 - p. 851-859 , 2014

Link: https://doi.org/10.1007/..

13

367 A first-in-human Phase 1 study of anti-CD105 antibody t..:

Rosen, L. ; Gordon, M.S. ; Hurwitz, H.I....
European Journal of Cancer Supplements. 8 (2010) 7 - p. 116 , 2010

Link: https://doi.org/10.1016/..

14

400 POSTER Early evidence of tolerability and clinical acti..:

Rosen, L.S. ; Gordon, M.S. ; Hurwitz, H.I....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 126 , 2008

Link: https://doi.org/10.1016/..

15

414 POSTER A phase I, open-label, dose escalation study of ..:

Gordon, M.S. ; Rosen, L.S. ; Robert, F....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 130 , 2008

Link: https://doi.org/10.1016/..